Precision Medicine Pioneer Files IPO Amid $215M Federal Initiative and Growing Clinical Adoption

On January 30 of this year, U.S. President Obama announced a $215 million Precision Medicine Initiative, aiming to achieve revolutionary breakthroughs in medicine. The initiative also encourages public participation to gather more scientific evidence, thereby facilitating the rapid integration of the concept of “Precision Medicine” into broader clinical practice. But what exactly is Precision Medicine?

What Is Precision Medicine/Personalized Medicine?

Precision medicine is generally translated as “precision medicine.” According to the definition provided by the National Research Council Committee, precision medicine refers to an approach that tailors disease prevention and treatment strategies to individual patient differences, representing a healthcare model that customizes medical interventions based on patient-specific characteristics. Unlike the traditional “one-size-fits-all” therapeutic approach, this model involves examining molecular and genomic information at the most granular level, enabling healthcare providers to appropriately adjust and modify diagnostic and treatment strategies in response to subtle variations in each patient’s data.

It is important to note that precision medicine does not entail developing a unique drug or therapeutic device specifically for an individual patient. Rather, it involves stratifying patients into distinct subgroups based on factors such as differential susceptibility to specific diseases and varied responses to particular treatments, thereby enabling the selection and modification of therapeutic approaches tailored to each subgroup.

In most cases, personalized medicine is used interchangeably with precision medicine. The National Research Council Committee explains these two highly similar medical terms as follows:

Precision Medicine refers to adjusting and modifying treatment approaches based on the individual characteristics of each patient. It does not entail developing specific drugs or medical devices for a particular individual; rather, it involves stratifying patients into distinct groups based on factors such as varying susceptibility to certain diseases and differential responses to specific therapeutic interventions, thereby enabling tailored selection and modification of treatment strategies. Both prevention and treatment efforts are focused on patients who are most likely to benefit, thus avoiding the waste of medical resources associated with ineffective therapies. Although the term “Personalized Medicine” is often used interchangeably, it is frequently misinterpreted as implying the creation of unique treatment regimens for every individual. Consequently, the National Research Council Committee favors the term Precision Medicine.

In other words, the terms “Precision Medicine” and “Personalized Medicine” have substantial overlap and are often used interchangeably; however, “Precision Medicine” is a more precise term.



Application of Precision Medicine/Personalized Medicine

The development of precision medicine/personalized medicine enables the creation of more precise and effective treatments tailored to individual and genetic differences. Precision medicine/personalized medicine offers unique advantages in early prevention, diagnosis, and drug development.

Diagnosis, Treatment, and Preventive Interventions

Precision medicine/personalized medicine enables patients to receive more accurate diagnoses and effective treatments. By thoroughly analyzing an individual’s genetic sequence, comparisons can be made across different patients’ genomes. For instance, through the Human Genome Project, it is possible to assess the likelihood of genetic variations associated with existing diseases. Currently, many companies have developed genetic sequencing services targeted at general consumers. Meanwhile, differences in individuals’ genetic makeup determine their varying responses to specific treatments; therefore, understanding these genetic differences is crucial for developing effective therapeutic strategies for patients. VCBeat has previously featured a company that specializes in providing personalized precision medicine services to patients. (For details, please clickMetaMed: Unlocking a New World of Personalized Medicine for Patients）

In addition to treatment, precision medicine/personalized medicine also represents a significant advance in preventive interventions. For instance, many women have an increased risk of developing breast or ovarian cancer due to family history. With the aid of precision medicine/personalized medicine, we can screen individuals for their likelihood of developing these diseases and implement tailored measures to prevent disease onset based on individual differences.

Drug Development and Use

Understanding individual genetic information is crucial for drug development. Whether detailed information about a patient’s genetic makeup is available is the decisive factor in determining their eligibility for late-stage clinical trials of a given drug. By identifying which patients derive the greatest therapeutic benefit and which are prone to adverse reactions during clinical trials, not only can the safety of the drug be enhanced, but the pace of clinical trials can also be accelerated, thereby reducing trial costs.

Cancer Genomics

In recent decades, with the deepening of cancer research, it has become increasingly evident that various cancers are associated with genetic differences among individuals. Cancer genomics employs genomics and precision medicine/personalized medicine to study and treat cancer. This approach enables a more comprehensive characterization of the relationship between cancer and genetics, as well as the impact of individual variations on cancer susceptibility.



 

Challenges Facing Precision Medicine/Personalized Medicine

As precision medicine/personalized medicine becomes increasingly widely adopted, challenges are gradually emerging. Meanwhile, current intellectual property regulations, reimbursement policies, patient privacy and data security, and regulatory frameworks all need to be redefined to accommodate the healthcare transformations driven by the development of precision medicine/personalized medicine. Furthermore, acquiring and analyzing the diverse data required for precision medicine/personalized medicine poses another significant challenge.

The main challenges facing precision medicine/personalized medicine include:

Government and Legal Regulation

For example, the FDA has already taken action to incorporate Precision Medicine/Personalized Medicine into its regulatory framework.

Intellectual Property Protection

As with other medical innovations, interest in and investment in Precision medicine/Personalized medicine are also influenced by intellectual property protection.

Reimbursement Policy

Reimbursement policies need to be adjusted accordingly to address the changes in healthcare brought about by the development of precision medicine/personalized medicine.

Patient Privacy and Data Security

This may be the most critical issue in the development of Precision Medicine/Personalized Medicine.